ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Frequency of Subclinic Hypothyroidism at the Patients That Are Using Valproic Acid

Mehmet Ibrahim Turan, Atilla Cayir, Ibrahim Selcuk Esin, Yasemin Cayir, Huseyin Tan.



Abstract
Download PDF Post

Valproic acid is one of the most commonly used anti-epileptics in the treatment of childhood epilepsy. The aim of this study was to determine the risk factors for and incidence of subclinical hypothyroidism (SH) in children with idiopathic epilepsy using valproic acid (VPA). Patients monitored with a diagnosis of idiopathic epilepsy, using valproic acid for longer than 12 months and who were seizure-free for at least 6 months were included in the study. Levels of free thyroxine, free triiodothyronine and thyrotropin were measured. The results were then compared with those of the control group. Rates of SH in patients using VPA and the control group were 18.5% and 6.2%, respectively. The difference was statistically significant (P0.01). In conclusion, SH is a common effect seen in children with epilepsy using VPA. It will be beneficial to measure thyroid functions at specific intervals.

Key words: Child, epilepsy, valproic acid, hypothyroidism







Bibliomed Article Statistics

39
41
35
31
20
43
43
42
45
47
42
19
R
E
A
D
S

14

13

8

14

14

16

12

9

29

17

22

9
D
O
W
N
L
O
A
D
S
040506070809101112010203
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.